Eds-flu (exhalation delivery system with fluticasone) benefits on nasal polyp disease relative to monoclonal antibodies

We report the effect of EDS-FLU on outcomes in a subgroup of patients with similar polyp burden to those enrolled in mAb studies.

Source: Annals of Allergy, Asthma and Immunology - November 1, 2018 Category: Allergy & Immunology Authors: N. Parikh, B. Chipps, J. Messina, J. Carothers, H. Sacks, R. Mahmoud Tags: A453 Source Type: research